Endometriosis: Ectopic Endometrial Tissue, Chronic Inflammation, and Pelvic Pain
Endometriosis is a chronic inflammatory condition characterised by the presence of endometrial-like tissue outside the uterine cavity, most commonly within the pelvis. Although hormonally responsive, this tissue lacks the normal mechanisms for organised shedding, leading to persistent inflammation, fibrosis, and pain.
What You Need to Know
Endometriosis develops when endometrial-like tissue establishes itself outside the uterine cavity and remains hormonally responsive. Like uterine endometrium, this ectopic tissue responds to cyclical oestrogen and progesterone exposure, thickening and breaking down across the menstrual cycle. Because it is located outside the uterus, there is no pathway for organised shedding or drainage. Instead, repeated cycles of stimulation lead to local bleeding, tissue irritation, and activation of immune and inflammatory pathways.
The resulting inflammatory environment extends beyond the ectopic lesions themselves. Immune cells are recruited, cytokines and prostaglandins are released, and surrounding tissues become involved in a chronic inflammatory response. Rather than resolving between cycles, inflammation accumulates over time, altering local tissue behaviour and pain signalling. This explains why symptoms often worsen progressively and why pain may persist outside menstruation.
Several interacting processes drive disease progression and symptom severity:
Cyclical hormonal stimulation of ectopic tissue without normal shedding
Recurrent local bleeding that provokes immune activation and inflammation
Progressive fibrosis, adhesion formation, and sensitisation of pelvic nerves
As inflammation persists, healing occurs through fibrosis rather than restoration of normal tissue planes. Adhesions form between pelvic organs, restricting movement and distorting anatomy, while inflammatory mediators lower pain thresholds within pelvic nerves. These changes explain why pain may become chronic, activity-related, or disproportionate to lesion size. Endometriosis is therefore best understood as a hormone-responsive inflammatory disorder with secondary structural and neurological consequences, rather than a condition defined solely by the presence of ectopic tissue.
Beyond the Basics
Theories of Disease Development
Several mechanisms have been proposed to explain how endometrial tissue establishes outside the uterus. Retrograde menstruation allows menstrual debris to enter the pelvic cavity, while immune dysfunction permits survival of ectopic cells that would normally be cleared. Other theories include coelomic metaplasia and lymphatic or vascular dissemination. Regardless of origin, disease persistence reflects failure of immune surveillance and abnormal inflammatory responses rather than implantation alone.
Hormonal Responsiveness and Local Oestrogen Production
Ectopic endometrial tissue is highly responsive to oestrogen. In addition to circulating hormones, lesions may produce oestrogen locally, amplifying their own growth and inflammatory activity. This local hormone production reduces responsiveness to normal hormonal feedback mechanisms and explains why symptoms may persist even when systemic hormone levels appear normal.
Chronic Inflammation and Immune Dysregulation
Endometriotic lesions provoke sustained immune activation. Macrophages, cytokines, and prostaglandins accumulate within the pelvic environment, maintaining a chronic inflammatory state. This inflammation sensitises nociceptors and lowers pain thresholds, explaining why pain can become disproportionate to lesion size and persist beyond menstruation. Chronic inflammation also contributes to fatigue and systemic symptoms.
Fibrosis, Adhesions, and Structural Distortion
Repeated cycles of inflammation and repair promote fibrosis. Scar tissue forms between pelvic organs, restricting mobility and distorting normal anatomy. Adhesions tether ovaries, bowel, and pelvic ligaments, contributing to deep pelvic pain, dyspareunia, and bowel or bladder symptoms. These structural changes explain why endometriosis pain is often progressive and multifactorial.
Neural Sensitisation and Persistent Pain
Endometriosis alters pelvic nerve pathways through direct nerve infiltration and inflammatory sensitisation. New nerve growth may occur within lesions, increasing pain transmission. Over time, central sensitisation may develop, where pain pathways remain activated even in the absence of active inflammation. This mechanism explains why pain may persist despite lesion suppression or surgical intervention.
Impact on Fertility
Endometriosis impairs fertility through inflammatory damage to ovarian tissue, altered tubal function, and distorted pelvic anatomy. Inflammatory mediators also affect oocyte quality and implantation. Fertility impairment reflects a hostile pelvic environment rather than mechanical obstruction alone, highlighting the systemic nature of the disease.
Clinical Connections
Endometriosis commonly presents with dysmenorrhoea, chronic pelvic pain, dyspareunia, bowel or bladder symptoms, and infertility. Pain may begin with menstruation but often extends beyond the cycle as inflammation and neural sensitisation progress. Importantly, symptom severity does not reliably correlate with the volume or visual extent of disease. Small or superficially appearing lesions may generate severe pain, while extensive disease may be relatively asymptomatic. Imaging can underestimate disease burden because microscopic lesions, fibrosis, and nerve involvement are not always visible.
Several features explain the disconnect between symptoms, imaging, and apparent disease extent:
Pain is driven by inflammatory mediators and nerve sensitisation rather than lesion size alone
Fibrosis and adhesions restrict organ mobility, producing pain with movement, intercourse, or bowel function
Central sensitisation lowers pain thresholds, allowing pain to persist even when active lesions are suppressed
Management therefore targets the mechanisms sustaining symptoms rather than focusing solely on lesion excision. Hormonal therapies aim to reduce cyclical stimulation of ectopic tissue, limiting recurrent bleeding and inflammatory activation. Anti-inflammatory and neuromodulatory approaches address ongoing immune activity and altered pain processing, while surgical intervention is reserved for specific indications such as obstructive disease, fertility optimisation, or refractory symptoms. Early recognition and intervention are critical, as prolonged inflammatory signalling and repeated nociceptive input increase the risk of chronic pain syndromes that persist even when hormonal activity is later controlled.
Concept Check
Why does ectopic endometrial tissue cause chronic inflammation rather than normal shedding?
How does local oestrogen production sustain endometriotic lesions?
Why can endometriosis pain persist outside the menstrual cycle?
How do adhesions contribute to pelvic pain and organ dysfunction?
Why is symptom severity poorly correlated with lesion size?